26 March 2020
UK Cambridge based technology brokerage company – Link China Pharma Solutions Helped Sareum Sign Global Licensing Deal for its FLT3+Aurora Kinase Inhibitor Programme with a China-based Specialty Pharma Company Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, is pleased to announce that it has entered into an agreement (the "Agreement") with a China-based specialty pharmaceutical company (the "Licensee).
Life Science SME's, your opportunity to share your business challenges during this turbulent time
As concerns around the coronavirus continue to grow, RSSL's top priority is to protect the health and welfare of our tutors, our team and our learners.
It is for this reason that we have made the decision to move all of our March, April and May 2020 training courses online.
These LIVE courses will be highly interactive, engaging and have the added benefit of saving learners travel and accommodation costs.
Arecor Extends Multi-Product Collaboration with Clinical Stage Biotech
Arecor innovative product formulations applied to oncology and rare orphan diseases
A specialist lab facility tailored to the commercialisation of life sciences on Newcastle Helix has welcomed new tenants as the ecosystem continues to grow.
The Biosphere is a high-quality building with office space and both chemistry and biology laboratories available. The new tenants, Biosignatures and Cognassist, add to the already impressive number of innovative life sciences organisations in the facility.
Cambridge, UK, 16 March 2020: TTP plc (TTP), a leading independent technology and product development company, today announced it has established a partnership with NHS Highland and The University of the Highlands and Islands, to use clinical data interpretation and machine learning algorithms to predict which patients with atrial fibrillation (AF) are able to be successfully treated using electrical cardioversion (ECV).
AMSBIO announce the availability of recombinant proteins and antibodies for detection of Coronavirus (COVID-19) and related RNA viruses.
Historically strains of Coronavirus able to infect humans (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoVHKU1) were not highly pathogenic and only caused mild respiratory illness. By comparison more recent strains - SARS-CoV, MERS-CoV and COVID-19 that emerged in Wuhan, China at the end of 2019 are highly pathogenic resulting in large scale pandemics.
AMSBIO offers a Skeletal Muscle Differentiation kit that enables you to differentiate human pluripotent stem cells to skeletal muscle myotubes with high yields, without cell sorting or genetic manipulation. Myotubes are contractile, express typical muscle markers that show striated sarcomeres.
If you work in the biotech, pharma, medical or related scientific area, and have marketing goals for 2020 - we would be grateful if you could fill out our 1 min marketing survey.
Onyva The Agency is looking for your expert input on its (very) short survey, to help serve the sector better. The poll includes entry into an optional prize draw of £100 worth of office treats. Anonymized results will be sent to participants.
Cambridge 05 March 2020: Introduced by the Babraham Research Campus in 2018, the Accelerate@Babraham initiative supports ambitious early stage life science ventures within the active Babraham Research Campus community. As part of this initiative StartUP@Babraham is a competition specifically to support ideas and/or companies that are pre-seed to seed stage (below £500k investment).